Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 5/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.76 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.76 |
| ▸ | XDH | P47989 | 5/20 | 0.76 |
| ▸ | MEN1 | O00255 | 5/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.76 |
| ▸ | IPMK | Q8NFU5 | 3/20 | 0.76 |
| ▸ | IP6K2 | Q9UHH9 | 3/20 | 0.76 |
| ▸ | CA12 | O43570 | 3/20 | 0.76 |
| ▸ | PPARG | P37231 | 3/20 | 0.76 |
| ▸ | CA7 | P43166 | 3/20 | 0.76 |
| ▸ | CA2 | P00918 | 2/20 | 0.76 |
| ▸ | CA4 | P22748 | 2/20 | 0.76 |
| ▸ | FTO | Q9C0B1 | 4/20 | 0.67 |
| ▸ | MAOA | P21397 | 3/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30255771 | 1.00 | ABCB1 (1.00) | ABCB1CYP1A1CYP1A2CYP1B1XDH | |
| Syringetin SCHEMBL29929167 | 0.92 | ABCB1 (0.85) | ABCB1CYP1A1CYP1A2CYP1B1XDH | |
| Syringetin SCHEMBL810981 | 0.92 | ABCB1 (0.85) | ABCB1CYP1A1CYP1A2CYP1B1XDH | |
| Laricytrin SCHEMBL19213534 | 0.91 | ABCB1 (0.83) | ABCB1CYP1A1CYP1A2CYP1B1XDH | |
| Laricytrin SCHEMBL29929477 | 0.91 | ABCB1 (0.83) | ABCB1CYP1A1CYP1A2CYP1B1XDH | |
| Mearnsetin SCHEMBL3690508 | 0.90 | ABCB1 (0.81) | ABCB1CYP1A1CYP1A2CYP1B1XDH | |
| SCHEMBL19249162 | 0.88 | ABCB1 (0.78) | ABCB1CYP1A1CYP1A2CYP1B1XDH | |
| SCHEMBL3452793 | 0.87 | ABCB1 (0.77) | ABCB1CYP1A1CYP1A2CYP1B1XDH | |
| SCHEMBL3211188 | 0.86 | MEN1 (0.86) | ABCB1CYP1A1CYP1A2CYP1B1XDH | |
| Isorhamnetin SCHEMBL19235 | 0.86 | MEN1 (1.00) | ABCB1CYP1A1CYP1A2CYP1B1XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115927238-B | Glycyrrhiza oxymethyl transferase and application thereof | 中国科学院华南植物园 | 2023-08-01 | — | — | CN | claimed |
| CN-115927238-A | Glycyrrhiza uralensis oxygen methyltransferase and application thereof | 中国科学院华南植物园 | 2023-04-07 | — | — | CN | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| US-20040242503-A1 | Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease | ATTENTION LABS INCORPORATED | 2004-12-02 | — | — | US | claimed |
| EP-1267853-B1 | COMPOSITIONS COMPRISING BLOCKERS OF L-DOPA RENAL CELL TRANSFER FOR THE TREATMENT OF PARKINSON'S DISEASE | PORTELA & CA SA (PT) | 2004-09-08 | — | — | EP | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| CN-115927238-B | Glycyrrhiza oxymethyl transferase and application thereof | 中国科学院华南植物园 | 2023-08-01 | — | — | CN | disclosed |
| CN-115927238-A | Glycyrrhiza uralensis oxygen methyltransferase and application thereof | 中国科学院华南植物园 | 2023-04-07 | — | — | CN | disclosed |
| EP-3763419-A1 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | Anji Pharma (US) LLC (US) | 2021-01-13 | — | — | EP | disclosed |
| EP-2661266-B1 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | ANJI PHARMA (US) LLC (US) | 2020-09-16 | — | — | EP | disclosed |
| US-9962344-B2 | Chemosensory receptor ligand-based therapies | ELCELYX THERAPEUTICS, INC. (US) | 2018-05-08 | — | — | US | disclosed |
| US-9962344-B2 | Chemosensory receptor ligand-based therapies | ELCELYX THERAPEUTICS, INC. (US) | 2018-05-08 | — | — | US | disclosed |
| WO-2003057210-A1 | COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
| US-20030125264-A1 | Methods For Treating Wounds | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-03 | — | — | US | disclosed |
| US-6555523-B1 | Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus | CASCADE ESTATES LTD. (MU) | 2003-04-29 | — | — | US | disclosed |
| US-6506792-B1 | Breast and endometrial cancers are major causes of death in Western women. In particular, tumours in endocrine-dependent tissues, such as the breast and endometrium, occur most frequently in postmenopausal women at a time when the ovaries | STERIX LIMITED (GB) | 2003-01-14 | — | — | US | disclosed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242503-A1 | Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease | COMT, DDC, AADAT | ABCB1 54/4885CYP1A1 1911/4885CYP1A2 3132/4885 |
| US-20030125264-A1 | Methods For Treating Wounds | FGF2, MMP1, FIBP | ABCB1 2498/4885CYP1A1 1856/4885CYP1A2 1713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.